| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cardiac Imaging |
1 From the Depts of Radiology (T.S., M.R., U.H., W.B., F.T., J.G., H.S.), Cardiology (C.V., W.J.), and Cardiovascular Surgery (C.S.), University of Bonn, Sigmund-Freud-Str 25, 53127 Bonn, Germany; Dept of Cardiology, Marienhof, Koblenz, Germany (G.L.); and Dept of Diagnostic Radiology, University Hospital of Zurich, München, Germany (A.v.S.). From the 1996 RSNA scientific assembly. Received April 5, 1999; revision requested May 20; revision received September 1; accepted November 22. Address correspondence to T.S. (e-mail: t.sommer@uni-bonn.de).
PURPOSE: To evaluate the safety and feasibility of magnetic resonance (MR) imaging at 0.5 T in patients with implanted cardiac pacemakers.
MATERIALS AND METHODS: Twenty-one models of pacemakers and 44 pacemaker electrodes were exposed to in vitro MR imaging with continuous registration of pacemaker output and temperature at the lead tip. Prior to MR imaging examination, pacemakers were programmed to an asynchronous mode (A00, V00, or D00). Pacemakers were examined before and after MR imaging. Forty-four patients with implanted pacemakers underwent 51 MR imaging examinations under cardiologic surveillance, continuous electrocardiography, pulse oximetry, and capnographic monitoring.
RESULTS: MR imaging was safely performed in all patients. None of the pacemakers displayed a pacing dysfunction at MR imaging. No changes occurred in the programmed parameters in any device tested in vivo or in vitro. Maximum increases in the temperature at the lead tips were 8.90°C at a specific absorption rate (SAR) of 0.6 W/kg and 23.50°C under a worst-case radio-frequency (RF) heating condition with an SAR of 1.3 W/kg.
CONCLUSION: MR imaging at 0.5 T can be safely performed in patients with implanted pacemakers in carefully selected clinical circumstances when appropriate strategies (programming to an asynchronous mode, adequate monitoring techniques, limited RF exposure) are used.
Index terms: Heart, pacemakers, 51.43, 51.456 • Magnetic resonance (MR), experimental studies, **.1214112, **.121412, **.121413, **.121416, 51.43, 51.456 • Magnetic resonance (MR), safety, **.121411, **.121412, **.121413, **.121416, 51.43, 51.456 • Phantoms
This article has been cited by other articles:
|
|
 |
|
  A. Roguin, J. Schwitter, C. Vahlhaus, M. Lombardi, J. Brugada, P. Vardas, A. Auricchio, S. Priori, and T. Sommer Magnetic resonance imaging in individuals with cardiovascular implantable electronic devices Europace, March 1, 2008; 10(3): 336 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. N. Levine, A. S. Gomes, A. E. Arai, D. A. Bluemke, S. D. Flamm, E. Kanal, W. J. Manning, E. T. Martin, J. M. Smith, N. Wilke, et al. Safety of Magnetic Resonance Imaging in Patients With Cardiovascular Devices: An American Heart Association Scientific Statement From the Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Council on Cardiovascular Radiology and Intervention: Endorsed by the American College of Cardiology Foundation, the North American Society for Cardiac Imaging, and the Society for Cardiovascular Magnetic Resonance Circulation, December 11, 2007; 116(24): 2878 - 2891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. P. Faris and M. Shein Food and Drug Administration Perspective: Magnetic Resonance Imaging of Pacemaker and Implantable Cardioverter-Defibrillator Patients Circulation, September 19, 2006; 114(12): 1232 - 1233. [Full Text] [PDF]
|
|
|
|
|
|
T. Sommer, C. P. Naehle, A. Yang, V. Zeijlemaker, M. Hackenbroch, A. Schmiedel, C. Meyer, K. Strach, D. Skowasch, C. Vahlhaus, et al. Strategy for Safe Performance of Extrathoracic Magnetic Resonance Imaging at 1.5 Tesla in the Presence of Cardiac Pacemakers in Non-Pacemaker-Dependent Patients: A Prospective Study With 115 Examinations Circulation, September 19, 2006; 114(12): 1285 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nazarian, A. Roguin, M. M. Zviman, A. C. Lardo, T. L. Dickfeld, H. Calkins, R. G. Weiss, R. D. Berger, D. A. Bluemke, and H. R. Halperin Clinical Utility and Safety of a Protocol for Noncardiac and Cardiac Magnetic Resonance Imaging of Patients With Permanent Pacemakers and Implantable-Cardioverter Defibrillators at 1.5 Tesla Circulation, September 19, 2006; 114(12): 1277 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Naehle, H. Litt, T. Lewalter, and T. Sommer Do we need pacemakers resistant to magnetic resonance imaging? Europace, January 1, 2006; 8(5): 388 - 388. [Full Text] [PDF]
|
|
|
|
|
|
W. E. Irnich Reply to the letter of Naehle et al. Europace, January 1, 2006; 8(5): 389 - 389. [Full Text] [PDF]
|
|
|
|
|
|
C. Vahlhaus Pacemakers (PM) and MRI. Europace, January 1, 2006; 8(5): 391 - 391. [Full Text] [PDF]
|
|
|
|
|
|
W. Irnich Reply to the letter of Vahlhaus. Europace, January 1, 2006; 8(5): 391 - 392. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sommer, C. P. Naehle, and H. Schild Magnetic Resonance Imaging in Patients With Cardiac Pacemakers J. Am. Coll. Cardiol., August 2, 2005; 46(3): 561 - 562. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Gimbel, B. L. Wilkoff, E. Kanal, and M. A. Rozner Safe, sensible, sagacious: responsible scanning of pacemaker patients Eur. Heart J., August 2, 2005; 26(16): 1683 - 1684. [Full Text] [PDF]
|
|
|
|
|
|
C. A. Chen-Scarabelli, T. M. Scarabelli, C. Vahlhaus, T. Sommer, C. P. Naehle, A. Roguin, M. M. Zviman, G. R. Meininger, T. M. Dickfeld, A. Lardo, et al. Letters Regarding Article by Roguin et al, "Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T" * Letters Regarding Article by Roguin et al, "Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T" * Letters Regarding Article by Roguin et al, "Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T" Circulation, June 14, 2005; 111(23): e390 - e392. [Full Text] [PDF]
|
|
|
|
|
|
R. H. Helm, C. Leclercq, O. P. Faris, C. Ozturk, E. McVeigh, A. C. Lardo, and D. A. Kass Cardiac Dyssynchrony Analysis Using Circumferential Versus Longitudinal Strain: Implications for Assessing Cardiac Resynchronization Circulation, May 31, 2005; 111(21): 2760 - 2767. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Luechinger, V. A. Zeijlemaker, E. M. Pedersen, P. Mortensen, E. Falk, F. Duru, R. Candinas, and P. Boesiger In vivo heating of pacemaker leads during magnetic resonance imaging Eur. Heart J., February 2, 2005; 26(4): 376 - 383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Martin Can cardiac pacemakers and magnetic resonance imaging systems co-exist? Eur. Heart J., February 2, 2005; 26(4): 325 - 327. [Full Text] [PDF]
|
|
|
|
|
|
W. Irnich, B. Irnich, C. Bartsch, W. A. Stertmann, H. Gufler, and G. Weiler Do we need pacemakers resistant to magnetic resonance imaging? Europace, January 1, 2005; 7(4): 353 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S K Prasad and D J Pennell Safety of cardiovascular magnetic resonance in patients with cardiovascular implants and devices Heart, November 1, 2004; 90(11): 1241 - 1244. [Full Text] [PDF]
|
|
|
|
 |
|
 T. B. Hunter, M. S. Taljanovic, P. H. Tsau, W. G. Berger, and J. R. Standen Medical Devices of the Chest RadioGraphics, November 1, 2004; 24(6): 1725 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. G. Shellock and J. V. Crues MR Procedures: Biologic Effects, Safety, and Patient Care Radiology, September 1, 2004; 232(3): 635 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Loewy, A. Loewy, and E. J. Kendall Reconsideration of Pacemakers and MR Imaging RadioGraphics, September 1, 2004; 24(5): 1257 - 1267. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Roguin, M. M. Zviman, G. R. Meininger, E. R. Rodrigues, T. M. Dickfeld, D. A. Bluemke, A. Lardo, R. D. Berger, H. Calkins, and H. R. Halperin Modern Pacemaker and Implantable Cardioverter/Defibrillator Systems Can Be Magnetic Resonance Imaging Safe: In Vitro and In Vivo Assessment of Safety and Function at 1.5 T Circulation, August 3, 2004; 110(5): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. T. Martin, J. A. Coman, F. G. Shellock, C. C. Pulling, R. Fair, and K. Jenkins Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1315 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Gimbel and E. Kanal Can patients with implantable pacemakers safely undergo magnetic resonance imaging? J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1325 - 1327. [Full Text] [PDF]
|
|
|
|
|
|
M. NIEHAUS and J. TEBBENJOHANNS Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators Heart, September 1, 2001; 86(3): 246 - 248. [Full Text] [PDF]
|
|
|
|
|
|
F. Duru, R. Luechinger, R. Candinas, T. Sommer, and H. Schild MR Imaging in Patients with Cardiac Pacemakers Drs Sommer and Schild respond: Radiology, June 1, 2001; 219(3): 856 - 858. [Full Text] [PDF]
|
|
|
|
|
|
F. G. Shellock MR Imaging and Electronically Activated Devices Radiology, April 1, 2001; 219(1): 294 - 295. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |
